Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vaxcyte, Inc.(PCVX) | 110,400 | 135,400 | +25,000 | $8.34M | $15.47M | 12.53% | +$7.14M |
| Ocular Therapeutix, Inc.(OCUL) | 2,771,130 | 1,190,071 | -1,581,059 | $18.95M | $10.35M | 8.39% | -$8.60M |
| Tourmaline Bio Inc | 269,614 | 332,095 | +62,481 | $3.47M | $8.54M | 6.92% | +$5.07M |
| Insmed Incorporated(INSM) | 72,100 | 107,500 | +35,400 | $4.83M | $7.85M | 6.36% | +$3.02M |
| Enliven Therapeutics Inc | 397,698 | 296,368 | -101,330 | $9.29M | $7.57M | 6.13% | -$1.72M |
| Crinetics Pharmaceuticals In | 135,141 | 131,700 | -3,441 | $6.05M | $6.73M | 5.45% | +$676.9K |
| Arcellx Inc COMMON STOCK | 42,200 | 62,100 | +19,900 | $2.33M | $5.19M | 4.20% | +$2.86M |
| Mereo BioPharma Group plcADS(MREO) | 677,000 | 1,260,700 | +583,700 | $2.44M | $5.18M | 4.20% | +$2.74M |
| Revolution Medicines, Inc.(RVMD) | 133,000 | 108,000 | -25,000 | $5.16M | $4.90M | 3.97% | -$263.9K |
| Taysha Gene Therapies, Inc.(TSHA) | 2,330,937 | 2,118,992 | -211,945 | $5.22M | $4.26M | 3.45% | -$962.1K |
| Terns Pharmaceuticals Inc | 369,280 | 487,000 | +117,720 | $2.51M | $4.06M | 3.29% | +$1.55M |
| Kura Oncology, Inc.(KURA) | 163,000 | 197,000 | +34,000 | $3.36M | $3.85M | 3.12% | +$493.2K |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,849,402 | 1,849,402 | 0 | $2.70M | $3.81M | 3.09% | +$1.11M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 250,370 | 190,000 | -60,370 | $5.39M | $3.51M | 2.84% | -$1.88M |
| Praxis Precision Medicines, Inc.(PRAX) | 164,431 | 57,500 | -106,931 | $6.80M | $3.31M | 2.68% | -$3.49M |
| argenx SEADR(ARGX) | 4,000 | 5,900 | +1,900 | $1.72M | $3.20M | 2.59% | +$1.48M |
| Ascendis Pharma A/SADR(ASND) | 0 | 21,000 | +21,000 | $0 | $3.14M | 2.54% | +$3.14M |
| COMPASS Pathways plcADS(CMPS) | 0 | 386,500 | +386,500 | $0 | $2.43M | 1.97% | +$2.43M |
| Mersana Therapeutics Inc | 1,663,000 | 1,200,000 | -463,000 | $3.34M | $2.27M | 1.84% | -$1.07M |
| Helix Acquisition Corp IiCL A | 177,836 | 180,945 | +3,109 | $1.82M | $1.89M | 1.53% | +$73.4K |
| Acelyrin Inc | 0 | 364,000 | +364,000 | $0 | $1.79M | 1.45% | +$1.79M |
| Edgewise Therapeutics, Inc.(EWTX) | 0 | 63,000 | +63,000 | $0 | $1.68M | 1.36% | +$1.68M |
| Dyne Therapeutics, Inc.(DYN) | 212,500 | 46,200 | -166,300 | $7.50M | $1.66M | 1.34% | -$5.84M |
| Gilead Sciences, Inc.(GILD) | 0 | 19,500 | +19,500 | $0 | $1.63M | 1.32% | +$1.63M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 25,100 | +25,100 | $0 | $1.39M | 1.13% | +$1.39M |
| Trevi Therapeutics, Inc.(TRVI) | 260,000 | 290,500 | +30,500 | $774.8K | $970.3K | 0.79% | +$195.5K |
| Unicycive Therapeutics Inc | 0 | 1,979,199 | +1,979,199 | $0 | $807.3K | 0.65% | +$807.3K |
| Liquidia Corporation(LQDA) | 0 | 73,500 | +73,500 | $0 | $735.0K | 0.60% | +$735.0K |
| Verve Therapeutics Inc | 0 | 146,100 | +146,100 | $0 | $707.1K | 0.57% | +$707.1K |
| Geron Corporation(GERN) | 0 | 154,900 | +154,900 | $0 | $703.2K | 0.57% | +$703.2K |
| Celcuity Inc.(CELC) | 45,000 | 46,600 | +1,600 | $737.1K | $694.8K | 0.56% | -$42.3K |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 44,000 | +44,000 | $0 | $679.8K | 0.55% | +$679.8K |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 13,700 | +13,700 | $0 | $415.1K | 0.34% | +$415.1K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 64,500 | 18,500 | -46,000 | $2.92M | $381.7K | 0.31% | -$2.54M |
| Rapport Therapeutics, Inc.(RAPP) | 20,000 | 17,600 | -2,400 | $465.2K | $360.4K | 0.29% | -$104.8K |
| Cypherpunk Technologies Inc.(CYPH) | 195,000 | 120,500 | -74,500 | $382.2K | $309.7K | 0.25% | -$72.5K |
| Climb Bio, Inc.(CLYM) | 0 | 54,000 | +54,000 | $0 | $274.9K | 0.22% | +$274.9K |
| Benitec Biopharma Inc.(BNTC) | 0 | 29,800 | +29,800 | $0 | $273.9K | 0.22% | +$273.9K |
| Travere Therapeutics, Inc.(TVTX) | 0 | 19,000 | +19,000 | $0 | $265.8K | 0.22% | +$265.8K |
| Third Harmonic Bio Inc | 0 | 15,508 | +15,508 | $0 | $210.1K | 0.17% | +$210.1K |
| Nuvation Bio Inc.W EXP 07 07 2027(NUVB) | 90,832 | 90,832 | 0 | $14.5K | $8.9K | 0.01% | -$5.6K |
| Agios Pharmaceuticals, Inc.(AGIO) | 78,700 | 0 | -78,700 | $3.39M | $0 | — | -$3.39M |
| Cellectar Biosciences, Inc.(CLRB) | 70,500 | 0 | -70,500 | $176.3K | $0 | — | -$176.3K |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 22,500 | 0 | -22,500 | $432.2K | $0 | — | -$432.2K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 96,000 | 0 | -96,000 | $678.7K | $0 | — | -$678.7K |
| Pliant Therapeutics, Inc.(PLRX) | 46,200 | 0 | -46,200 | $496.6K | $0 | — | -$496.6K |
| Sarepta Therapeutics, Inc.(SRPT) | 27,500 | 0 | -27,500 | $4.34M | $0 | — | -$4.34M |
| Viridian Therapeutics, Inc.(VRDN) | 199,433 | 0 | -199,433 | $2.59M | $0 | — | -$2.59M |